IQVIA Holdings' (NYSE:IQV) Investors Will Be Pleased With Their Decent 52% Return Over the Last Five Years
J&J Leads H1 Healthcare Deals as Big Pharma Dealmaking Returns: Report
Goldman Thinks IQVIA Holdings Inc. (IQV) Is A Long-Term AI Stock Set To Rally Eventually
Is IQVIA Holdings Stock Underperforming the S&P 500?
Supernus Cut to Neutral at Piper Sandler on Qelbree Growth Trajectory
IQVIA Applauded by Frost & Sullivan for Improving the Performance of QARA Professionals, Patient Safety, and Commercial Performance With Its AI Solutions
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 38% Undervaluation?
Does IQVIA Holdings (NYSE:IQV) Deserve A Spot On Your Watchlist?
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating
Truist Financial analyst Jailendra Singh maintains $IQVIA Holdings(IQV.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 35.2% and a total average return of -13.7%
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV) and BioMarin Pharmaceutical (BMRN)
Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst
'Brighter Skies' Ahead for IQVIA As EPS Set to 'Reaccelerate', RBC Capital Says
Breaking Down IQVIA Hldgs: 12 Analysts Share Their Views
IQVIA Hldgs Analyst Ratings
Signant Health Expands Availability of Its EClinical Solutions by Joining IQVIA One Home for Sites Initiative
RBC Initiates IQVIA Holdings at Outperform With $275 Price Target
RBC Capital Initiates IQVIA Holdings(IQV.US) With Buy Rating, Announces Target Price $275
RBC Capital analyst Sean Dodge initiates coverage on $IQVIA Holdings(IQV.US)$ with a buy rating, and sets the target price at $275.According to TipRanks data, the analyst has a success rate of 42.5%
IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?